查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056439

免疫組織化學市場報告：按產品、應用、最終用途和地區分類（2026-2034 年）

Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End Use (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球免疫組織化學市場規模達30億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到52億美元，2026年至2034年的複合年成長率為6.02%。慢性病盛行率上升、對個人化醫療的需求不斷成長、診斷技術的顯著進步、醫療基礎設施投資的增加以及人口老化是推動市場成長的主要因素。

免疫組織化學市場趨勢：

慢性病盛行率增加

慢性疾病（包括癌症）發生率的上升推動了對精準診斷和預後工具的需求。免疫組織化學對於檢測癌症和其他疾病的生物標記至關重要，有助於制定精準的診斷和治療方案。世界衛生組織（WHO）發布的數據顯示，2022年全球新增癌症病例約2,000萬例，死亡病例約970萬例。約有5350萬人在確診癌症後存活五年。大約五分之一的人一生中會罹患癌症，約九分之一的男性和十二分之一的女性會死於癌症。領先企業正積極應對這項需求激增的局面，推出更有效的產品和服務。例如，2024年4月，生命科學研究和臨床診斷產品領域的全球領導者Bio-Rad Laboratories, Inc.宣布推出首款超靈敏多重數位PCR檢測產品－ddPLEX ESR1突變檢測試劑盒。此檢測方法擴展了該公司面向腫瘤市場的液滴數位PCR (ddPCR)產品組合。這種高靈敏度、多重突變檢測方法將有助於轉化研究、治療方法選擇和疾病監測。預計這將進一步推動未來幾年免疫組織化學市場的成長。

顯著的技術進步

顯微鏡、染色和數位成像技術的進步顯著提升了免疫組織化學技術的有效性和效率，使其成為組織分析的首選方法。例如，2023年5月，全球領先的醫療技術公司BD（貝克頓·迪金森公司）宣佈在全球推出一款全新的細胞分選系統。該系統融合了兩項突破性技術，使研究人員能夠獲取傳統流式細胞技術實驗無法捕捉到的細胞詳細資訊。 BD CellView影像技術使研究人員能夠查看單一細胞的詳細顯微影像，並透過基於視覺特徵的快速分選，即時檢驗研究結果。 BD SpectalFX技術則實現了全光譜細胞分選，並藉助全新的模組化光學架構和系統識別演算法，顯著提升了性能，使研究人員能夠在簡化的工作流程中開展高參數實驗。

個人化醫療正日益受到關注。

隨著腫瘤學領域個人化醫療的推進，免疫組織化學在識別特定分子標靶和提供針對每位患者個別特徵的客製化治療方面的需求日益成長，有望改善治療效果。例如，2023年6月，全球科學領域的領導者賽默飛世爾科技宣布推出Gibco OncoPro腫瘤類器官培養基試劑盒，這是首個專為培養來自多種癌症適應症的患者來源腫瘤樣組織（癌類器官）而開發的商用培養基。同樣，2023年1月，位於班加羅爾的阿波羅癌症中心開設了印度首個人工智慧驅動的精準腫瘤中心（POC）。這項重大措施將大幅提升腫瘤治療的品質。該中心將充分利用人工智慧的巨大潛力，幫助腫瘤科醫生、患者及其看護者在規定的時間內取得最佳治療效果。這正在對全球免疫組織化學市場的收入產生影響。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球免疫組織化學市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 抗體
    • 主要部分
      • 一抗
      • 二抗
  • 裝置
    • 主要部分
      • 玻片染色系統
      • 組織微陣列
      • 組織處理系統
      • 幻燈片掃描儀
      • 其他
  • 試劑
    • 主要部分
      • 組織染色
      • 封閉血清和試劑
      • 呈色受質
      • 固定試劑
      • 穩定器
      • 有機溶劑
      • 蛋白質分解酶
      • 沖淡
  • 成套工具

第7章 市場區隔：依應用領域分類

  • 診斷
    • 主要部分
      • 癌症
      • 感染疾病
      • 心血管疾病
      • 自體免疫疾病
      • 糖尿病
      • 腎臟疾病
  • 藥物檢測

第8章 市場區隔：依最終用途分類

  • 醫院/診斷檢查室
  • 研究機構
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abcam plc
    • Agilent Technologies Inc.
    • Beckman Coulter Inc.（Danaher Corporation）
    • Becton Dickinson and Company
    • Bio SB Inc.
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4404

The global immunohistochemistry market size reached USD 3.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.2 Billion by 2034, exhibiting a growth rate (CAGR) of 6.02% during 2026-2034. The rising prevalence of chronic diseases, the increasing demand for personalized medicines, significant advancements in diagnostic techniques, growing investments in healthcare infrastructure, and the rising aging population are some of the major factors propelling the growth of the market.

Immunohistochemistry Market Analysis:

  • Major Market Drivers: The growing incidence of infectious and chronic diseases which necessitate advanced diagnostic solutions represent the major drivers of the market. The widespread adoption of personalized medicine, which relies heavily on biomarker identification is further stimulating the demand for immunohistochemistry. Significant technological advancements in diagnostic techniques enhance the accuracy and efficiency of immunohistochemistry tests.
  • Key Market Trends: The increasing integration and automation of advanced imaging technologies to enhance diagnostic throughput and accuracy represents one of the key trends in the market. The rising shift toward companion diagnostic and precision medicine, emphasizes personalized treatment strategies. The growing development of multiplex assays allows simultaneous detection of multiple biomarkers thus increasing efficiency.
  • Geographical Trends: North America accounts for the largest region in the immunohistochemistry market. The strong emphasis on cancer research and diagnostic advancements in Canada and the US is driving the market growth. This is primarily due to the substantial healthcare spending and well-established medical infrastructure. The widespread adoption of personalized medicine and biomarker-based testing, particularly in oncology is fueling the market growth across the region.
  • Competitive Landscape: Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: The market faces various challenges in the market including high costs associated with advanced imaging systems and reagents, a lack of skilled professionals capable of interpreting complex immunohistochemical data, and strict regulatory requirements for product approvals. However, the market faces several opportunities such as the rising demand for personalized medicine and targeted therapies that rely heavily on immunohistochemical markers for effective treatment planning.

Immunohistochemistry Market Trends:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases including cancer is driving the demand for accurate diagnostic and prognostic tools. Immunohistochemistry is crucial for detecting biomarkers in cancer and other diseases, thus aiding in precise diagnosis and treatment planning. According to data published by the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime, and approximately 1 in 9 men and 1 in 12 women die from the disease. This surge is aptly met by the key players by introducing more effective products and services. For instance, in April 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. The assay expands the company's Droplet Digital PCR (ddPCR) offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, and disease monitoring. This is further expected to boost the immunohistochemistry market forecast over the coming years.

Significant Technological Advancement

The growing technological innovations in microscopy, staining techniques, and digital imaging enhance the effectiveness and efficiency of immunohistochemistry procedures, thereby making it a preferred method for detailed tissue analysis. For instance, in May 2023, BD (Becton, Dickinson, and Company), a leading global medical technology company, announced the worldwide commercial launch of a new world sales sorting instrument offering two breakthrough technologies that enable researchers to uncover more detailed information about sales that were previously invisible in traditional flow cytometry experiments. With BD CellView Image Technology, researchers can see detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time. With BD SpectalFX Technology, researchers can achieve full spectrum cell sorting, coupled with expanded performance enabled by a new modular optical architecture and system-aware algorithms, to perform high parameter experiments within a simplified workflow.

Rising Focus on Personalized Medicine

The increasing shift toward personalized medicine, especially in oncology, is driving the need for immunohistochemistry to identify specific molecular targets and tailor treatments to individual patient profiles, thus improving therapeutic outcomes. For instance, in June 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of Gibco OncoPro Tumor Roid Culture Medium Kit, the first commercially available culture medium specifically developed for the expansion of patient-derived tumoroids, or cancer organoids, from multiple cancer indications. Similarly, in January 2023, Apollo Cancer Center, Bengaluru, launched India's first AI Precision Oncology Center (POC) in a significant move that will substantially enhance the quality of oncology care. The Center will help the oncologists, patients, and caregivers to arrive at the best possible results in a time-bound manner the enormous possibilities offered by AI. This is influencing the immunohistochemistry market revenue across the globe.

Immunohistochemistry Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on product, application, and end-use.

Breakup by Product:

  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Equipment
  • Slide Staining Systems
  • Tissue Microarrays
  • Tissue Processing Systems
  • Slide Scanners
  • Others
  • Reagents
  • Histological Stains
  • Blocking sera and Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Stabilizers
  • Organic Solvents
  • Proteolytic Enzymes
  • Diluents
  • Kits

Antibodies accounts for the majority of the market share

The increasing need for disease diagnosis and research, especially cancers and infectious diseases is elevating the demand for specific antibodies. The rising innovations in antibody engineering improve specificity and sensitivity, enhancing diagnostic accuracy. The expanding biomedical research necessitates diverse antibodies for detailed cellular and molecular studies. Personalized treatment approaches require precise biomarker identification, boosting the use of targeted antibodies. For instance, in August 2023, Regeneron Pharmaceuticals, Inc. announced that the Biomedical Advanced Research and Development (BARDA)authority has agreed with Regeneron to support clinical development, clinical manufacturing, and the regulatory licensure process of on next-generation COVID-19 monoclonal antibody therapy for the prevention of SARS-CoV-2 infection.

Breakup by Application:

  • Diagnostics
  • Cancer
  • Infectious Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases
  • Drug Testing

Diagnostics holds the largest share of the industry

The increasing cases of cardiovascular, infectious diseases, cancer, autoimmune, nephrological conditions, and diabetes necessitate advanced diagnostic methods. In line with this, the enhancing focus on personalized treatment plans based on specific biomarkers detected through immunohistochemistry. Significant improvements in staining techniques and emerging technologies improve the accuracy and efficiency of disease diagnosis. The growing research activities require detailed cellular analysis, promoting the use of immunohistochemistry in understanding disease mechanisms and pathology. This is further driving the demand for diagnostics in the immunohistochemistry market growth.

Breakup by End-Use:

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

Hospitals and Diagnostic Laboratories represents the leading market segment

The rising rates of chronic diseases particularly cancers, are driving the demand for precise diagnostic tools such as immunohistochemistry to accurately identify and classify disease states. Significant innovations in digital imaging systems and staining techniques enhance the diagnostic capabilities and throughput of immunohistochemistry, making it more appealing for clinical settings. The rising focus on adherence to high quality and regulatory standards in diagnostic processes necessitates reliable techniques like immunohistochemistry. The increasing investments in healthcare infrastructure and diagnostic services boost the adoption of advanced diagnostic methods, such as immunohistochemistry, in both developed and emerging markets.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest immunohistochemistry market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for immunohistochemistry.

The rising cases of cancer and other chronic conditions are driving the demand for precise diagnostic methods like immunohistochemistry to identify biomarkers for effective treatment which is influencing the market growth across the region. The well-established healthcare facilities and robust funding research and development (R&D) are facilitating the adoption of advanced diagnostic technologies. According to the data from the National Library of Medicine, in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.
  • The market is highly competitive, with key players like Agilent Technologies, Thermo Fisher Scientific, and Roche Diagnostics dominating. These players focus on innovation and strategic partnerships to enhance their product portfolios. Other significant companies such as Merk Group, Bio-Rad Laboratories, and Danaher Corporation, emphasize expanding their global footprints through collaborations and acquisitions. In February 2023, Agilent Technologies Inc. introduced an integrated solution that combines their xCELLigence RTCA HT platform with the Bio Tek BioSpa 8 Automated Incubator. This new development offers a higher level of workflow automation, allowing further creation of label-free high throughput potency assays for immune-oncology and high throughput viral cytopathic effects (CPE) assays for the vaccine market.

Key Questions Answered in This Report:

  • How has the global immunohistochemistry market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global immunohistochemistry market?
  • What is the impact of each driver, restraint, and opportunity on the global immunohistochemistry market?
  • What are the key regional markets?
  • Which countries represent the most attractive immunohistochemistry market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the immunohistochemistry market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the immunohistochemistry market?
  • What is the breakup of the market based on the end-use?
  • Which is the most attractive end-use in the immunohistochemistry market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global immunohistochemistry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohistochemistry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Primary Antibodies
      • 6.1.2.2 Secondary Antibodies
    • 6.1.3 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Slide Staining Systems
      • 6.2.2.2 Tissue Microarrays
      • 6.2.2.3 Tissue Processing Systems
      • 6.2.2.4 Slide Scanners
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Histological Stains
      • 6.3.2.2 Blocking sera and Reagents
      • 6.3.2.3 Chromogenic Substrates
      • 6.3.2.4 Fixation Reagents
      • 6.3.2.5 Stabilizers
      • 6.3.2.6 Organic Solvents
      • 6.3.2.7 Proteolytic Enzymes
      • 6.3.2.8 Diluents
    • 6.3.3 Market Forecast
  • 6.4 Kits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Cancer
      • 7.1.2.2 Infectious Diseases
      • 7.1.2.3 Cardiovascular Diseases
      • 7.1.2.4 Autoimmune Diseases
      • 7.1.2.5 Diabetes Mellitus
      • 7.1.2.6 Nephrological Diseases
    • 7.1.3 Market Forecast
  • 7.2 Drug Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio SB Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Bio-Rad Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Bio-Techne Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Cell Signaling Technology Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 F. Hoffmann-La Roche AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Perkinelmer Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohistochemistry Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Immunohistochemistry Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Immunohistochemistry Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Immunohistochemistry Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Immunohistochemistry Market: Breakup by End Use (in %), 2025
  • Figure 6: Global: Immunohistochemistry Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Immunohistochemistry (Antibodies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Immunohistochemistry (Antibodies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Immunohistochemistry (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Immunohistochemistry (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Immunohistochemistry (Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Immunohistochemistry (Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Immunohistochemistry (Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Immunohistochemistry (Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Immunohistochemistry (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Immunohistochemistry (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Immunohistochemistry (Drug Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Immunohistochemistry (Drug Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Immunohistochemistry (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Immunohistochemistry (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Immunohistochemistry (Other End Uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Immunohistochemistry (Other End Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: North America: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: North America: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: United States: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: United States: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Canada: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Canada: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Asia-Pacific: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Asia-Pacific: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: China: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: China: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Japan: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Japan: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: India: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: India: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: South Korea: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: South Korea: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Australia: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Australia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Indonesia: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Indonesia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Europe: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Europe: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Germany: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Germany: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: France: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: France: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: United Kingdom: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: United Kingdom: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Italy: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Italy: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Spain: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Spain: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Russia: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Russia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Latin America: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Latin America: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Brazil: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Brazil: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Mexico: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Mexico: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Middle East and Africa: Immunohistochemistry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Middle East and Africa: Immunohistochemistry Market: Breakup by Country (in %), 2025
  • Figure 73: Middle East and Africa: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Global: Immunohistochemistry Industry: SWOT Analysis
  • Figure 75: Global: Immunohistochemistry Industry: Value Chain Analysis
  • Figure 76: Global: Immunohistochemistry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohistochemistry Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Immunohistochemistry Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Immunohistochemistry Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Immunohistochemistry Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 5: Global: Immunohistochemistry Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Immunohistochemistry Market: Competitive Structure
  • Table 7: Global: Immunohistochemistry Market: Key Players